|
Tax & Financial | Stock Options Archive
Testimony on FASB and Small Business Growth
Walter K. Moore, Vice President, Government Affairs, Genentech, Inc. (Nov. 12, 2003)
Read the testimony. (123 KB PDF)
S. 979 & H.R. 1372, the Broad-Based Stock Option Plan Transparency Act of 2003
Letter to Sens. John Ensign and Barbara Boxer, Reps. David Dreier and Anna Eshoo (June 2, 2003)
Read the letter (70 KB PDF)
Support H.R. 1372
Fact sheet from the Coalition to Preserve and Protect Stock Options (May 12, 2003)
Read the fact sheet
Support S. 979
Fact sheet from the Coalition to Preserve and Protect Stock Options (May 12, 2003)
Read the fact sheet
Letter to Representatives Eshoo & Dreier
in support of HR 1372 (April 16, 2003)
Read the letter
Letter signed by Senators Bingaman and Hatch
Letter regarding Employee Stock Purchase Plans (ESPPs) and Incentive Stock Options (ISOs) legislation in 2003 (March 26, 2003)
Read the letter (104 KB PDF)
BIO's comments to the Financial Accounting Standards Board (FASB)
opposing the expensing of stock options (Jan. 31, 2003)
Read the comments
Stock Options and Employment Tax Withholding
A fact sheet from The Stop Higher Payroll Taxes Coalition (Jan. 29, 2003)
Read the fact sheet
BIO's Comments to the FASB
Comments to the Financial Accounting Standards Board Regarding the Expensing of Stock Options (November 8, 2002)
Read the comments (1.63 MB PDF)
Letter from the Stop Higher Payroll Taxes Coalition
in support for legislative action to clarifying that statutory stock options are not subject to payroll taxes (September 23, 2002)
Read the letter
Opposing S. 1940 and HR 4075
126 CEO's send open letter to Congress aopposing stock option legislation (June 4, 2002)
Read the letter
Coalition to Preserve and Protect Stock Options letter
thanking Senator Michael Enzi (R-WY) for April 18th testimony (April 29, 2002)
Read the letter
BIO Comments to the IRS
on Proposed Regulation on Stock Option Withholding (April 23, 2002)
Read the comments
Coalition to Preserve and Protect Stock Option letter
to House of Representatives opposing HR 4075 Stark-Frank-Rivers Stock Options Tax Bill (April 8, 2002)
Read the letter
Senate Testimony of David E. Robinson
CEO of Ligand Pharmaceuticals, on Accounting Practices and Biotechnology (June 28, 2000)
Read the testimony (5.7 MB PDF)
Current Stock Options Information
Browse the Stock Options issue page
| 
